6 completed, 1 unknown. .
Follow Orlucent, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| INTER-PATHOLOGIST READER STUDY Nevi, Dysplastic | Unknown | Orlucent, Inc | 500 | 2023-06-15 | 2024-02-07 | |
| Skin Fluorescent Imaging (SFI) System in Patients With Nevi Skin Fluorescent Imaging - Nevus, Dysplasia; Epithelial | Completed | Orlucent, Inc | 300 | 2020-08-10 | 2025-08-07 | |
| Investigating the Clinical Utility of the MDS Melanoma Detection System -MDS - Skin Lesion, Melanoma | Completed | Orlucent, Inc | 250 | 2018-04-01 | 2020-11-19 | |
| Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging) Diagnostic Test - Skin Lesion, Melanoma (Skin) | Completed | Orlucent, Inc | 186 | 2018-01-24 | 2024-01-10 | |
| Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging MDS - Skin Lesion | Completed | Orlucent, Inc | 50 | 2017-08-30 | 2018-02-19 | |
| Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging Skin Lesions | Completed | Orlucent, Inc | 357 | 2016-07-01 | 2020-11-18 | |
| Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection. Skin Lesions | Completed | Orlucent, Inc | 126 | 2013-06-01 | 2018-02-19 |
Dysplastic Nevus Syndrome (3) · Melanoma (3) · Nevus (3) · Carcinoma in Situ (1) · Skin Neoplasms (1)
United States (3) · Israel (2) · United Kingdom (1)
Cathy Shachaf, PhD (3) · Sharon Merims, MD (1) · Shokrey Kassis, MA (1) · Yehuda Ullmann, MD (1)